Antiproliferative properties of chemically modified recombinant IFN-α2b

被引:4
|
作者
Martynov, AV [1 ]
Smelyanskaya, MV [1 ]
机构
[1] AMS Ukraine, II Mechnikov Inst Microbiol & Immunol, UA-61057 Kharkov, Ukraine
来源
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 2005年 / 25卷 / 07期
关键词
D O I
10.1089/jir.2005.25.414
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The antiproliferative activity of aconitylated (AIFN) and succinylated (SIFN) derivatives of recombinant interferon-alpha 2b (IFN-alpha 2b) was examined. Acylation of IFN-alpha 2b was performed by succinic and cis-aconitic anhydrides. Antiproliferative properties of AIFN and SIFN were studied in vitro on the CaOv cell line, highly sensitive to IFN, and on the SW-480 cell line, with low sensitivity to IFN-alpha 2b. Acylation of one lysine in the IFN-alpha 2b molecule with cis-aconitic or succinic anhydride resulted in a 3 - 3.5-fold increase of its antiproliferative activity on CaOv cells. The highest antiproliferative activity of acylated IFN-alpha 2b on SW-480 cells was observed for both AIFNs and SIFNs with three modified lysine residues. In conclusion, aconitylated and succinylated IFNs may be useful antiproliferative agents for cancer treatment.
引用
收藏
页码:414 / 417
页数:4
相关论文
共 50 条
  • [21] Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency
    Rosain, Jeremie
    Kiykim, Ayca
    Michev, Alexandre
    Kendir-Demirkol, Yasemin
    Rinchai, Darawan
    Peel, Jessica N.
    Li, Hailun
    Ocak, Suheyla
    Ozdemir, Pinar Gokmirza
    Le Voyer, Tom
    Philippot, Quentin
    Khan, Taushif
    Neehus, Anna-Lena
    Migaud, Melanie
    Soudee, Camille
    Boisson-Dupuis, Stephanie
    Marr, Nico
    Borghesi, Alessandro
    Casanova, Jean-Laurent
    Bustamante, Jacinta
    JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (03)
  • [22] Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency
    Jérémie Rosain
    Ayca Kiykim
    Alexandre Michev
    Yasemin Kendir-Demirkol
    Darawan Rinchai
    Jessica N. Peel
    Hailun Li
    Suheyla Ocak
    Pinar Gokmirza Ozdemir
    Tom Le Voyer
    Quentin Philippot
    Taushif Khan
    Anna-Lena Neehus
    Mélanie Migaud
    Camille Soudée
    Stéphanie Boisson-Dupuis
    Nico Marr
    Alessandro Borghesi
    Jean-Laurent Casanova
    Jacinta Bustamante
    Journal of Clinical Immunology, 2024, 44
  • [23] Intralesional IFN-α2b benefits men with Peyronie's disease
    Nature Clinical Practice Urology, 2006, 3 (9): : 458 - 458
  • [24] Treatment of refractory bullous pemphigoid with IFN-α-2b: A case report
    Wang, Tianjing
    Xu, Yingping
    Ren, Yingying
    Luo, Guangpu
    DERMATOLOGIC THERAPY, 2020, 33 (02)
  • [25] Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-β Mediation
    Hurtado-Guerrero, Isaac
    Hernaez, Bruno
    Pinto-Medel, Maria J.
    Calonge, Esther
    Rodriguez-Bada, Jose L.
    Urbaneja, Patricia
    Alonso, Ana
    Mena-Vazquez, Natalia
    Aliaga, Pablo
    Issazadeh-Navikas, Shohreh
    Pavia, Jose
    Leyva, Laura
    Alcami, Jose
    Alcami, Antonio
    Fernandez, Oscar
    Oliver-Martos, Begona
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [26] Polymorphous light eruption-like lesions on sun-protected injection sites of recombinant IFN-α-2b
    Nikkels, AF
    Delwaide, J
    Letawe, C
    Pierard, GE
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1997, 8 (04) : 285 - 285
  • [27] Improved yield of recombinant human IFN-α2b from mammalian cells using heterologous signal peptide approach
    Wilkinson, Claire
    Kyle, Jacob
    Irimpen, Meghna
    Stuart, Sarah
    Mohandass, Shylaja
    Sheperd, Andrew
    Smith, Kathrine J.
    Mullin, Michael J.
    PROTEIN EXPRESSION AND PURIFICATION, 2022, 198
  • [28] IFN-α2b and thalidomide synergistically inhibit tumor-induced angiogenesis
    Bauer, JA
    Morrison, BH
    Grane, RW
    Jacobs, BS
    Borden, EC
    Lindner, DJ
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2003, 23 (01): : 3 - 10
  • [29] Phase I clinical and gene modulatory evaluation of tamoxifen and IFN-α2b
    Thakkar, Snehal G.
    Peereboom, David
    Olencki, Thomas
    Jacobs, Barbara
    Elson, Paul
    Rybicki, Lisa
    Lindner, Daniel J.
    Borden, Ernest C.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2006, 26 (11): : 800 - 803
  • [30] Efficacy and toxicity of IFN-α2b combined with cytarabine in chronic myelogenous leukaemia
    Lindauer, M
    Domkin, D
    Döhner, H
    Kolb, HJ
    Neubauer, A
    Huhn, D
    Kreiter, H
    Koch, B
    Huber, C
    Aulitzky, W
    Fischer, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (04) : 1013 - 1019